Business

2026 RESULT OF ANNUAL GENERAL MEETING

ImmuPharma PLC announced the results of its Annual General Meeting, confirming that all six resolutions, including the re-appointment of Ketan Patel as director and Crowe UK LLP as auditor, were passed by shareholders with strong support, ranging from 93% to 99% of votes cast. The company also received shareholder approval for directors to allot shares and adopt new Articles of Association, with 152,641,450 shares (94%) voting in favour of the first share allotment resolution and 151,322,867 shares (93%) for the second special resolution. The total number of issued ordinary shares eligible to vote was 623,911,379. Disclaimer*

articleImmupharma PlcJune 25, 20264/news/2026-result-of-annual-general-meeting
2026 RESULT OF ANNUAL GENERAL MEETING

About this update from Immupharma Plc

    RNS: RELEASE                                                                                                                                                    25 June 2026   ImmuPharma PLC ("ImmuPharma" or the "Company")   2026 RESULT OF ANNUAL GENERAL MEETING ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, held its AGM earlier today. The Company is pleased to announce that six of the six resolutions (Resolutions 1 - 6 inclusive) were duly passed by shareholders. Details are contained in the table below. Resolution For % For Against % Against Withheld 1. To receive the accounts of the Company for the year ended 31 December 2025 together with the reports thereon of the directors and auditors of the Company 163,496,678 99 2,252,180 1 365,965 2. To re-appoint Ketan Patel as a director of the Company 156,211,793 98 3,080,916 2 6,822,114 3. To re-appoint Crowe UK LLP as Auditor of the Company 163,482,368 99 2,311,240 1 321,215 4. That the directors be authorised for the purpose of Section 551 of the Companies Act 2006 (the "Act") to allot shares on the basis as set out in the Notice of Meeting 152,641,450 94 11,960,794 6 1,512,579 SPECIAL RESOLUTION 5. That the directors be authorised for the purpose of Section 551 of the Companies Act 2006 (the "Act") to allot shares on the basis as set out in the Notice of Meeting 151,322,867 93 13,507,185 7 1,284,771 SPECIAL RESOLUTION 6. That, with effect from the conclusion of the Annual General Meeting, the draft Articles of Association be adopted as the Articles of Association of the Company in substitution for, and to the exclusion of, ...

View stock analysis, news, and events for Immupharma Plc